Also trades as: NRXP (NASDAQ) · $vol 3M
NRXPW NASDAQ
NRx Pharmaceuticals, Inc.
1W: -49.5%
1M: +0.0%
3M: -84.9%
YTD: -92.2%
1Y: -94.1%
3Y: -97.7%
5Y: -97.3%
$0.01
-0.00 (-12.94%)
Weekly Expected Move ±102.6%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.0051-0.1602
Volume23,367
Avg Volume19,460
Beta1.73
Dividend—
Analyst Ratings
Company Info
CEOJonathan C. Javitt
Employees10
SectorHealthcare
IndustryBiotechnology
IPO Date2017-12-01
Websitenrxpharma.com
1201 Orange Street
Wilmington, DE 19801
US
Wilmington, DE 19801
US
484 254 6134
About NRx Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Latest News
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Rating of “Moderate Buy” from Analysts
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Average Recommendation of “Moderate Buy” from Analysts
What is HC Wainwright’s Estimate for NRXP FY2026 Earnings?
HC Wainwright Issues Pessimistic Outlook for NRXP Earnings
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Casper Joseph Michae | A-Award | 100,000 | $2.39 | 2026-01-27 |
| Casper Joseph Michae | 100,000 | $2.39 | 2026-01-27 | |
| B Group, Inc. | 0 | — | 2025-08-18 | |
| Javitt Jonathan C | A-Award | 125,000 | $1.73 | 2025-04-09 |
| McBride Dennis | A-Award | 25,000 | $1.73 | 2025-04-09 |